Suzu Igarashi

1.1k total citations · 1 hit paper
16 papers, 849 citations indexed

About

Suzu Igarashi is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Suzu Igarashi has authored 16 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Suzu Igarashi's work include Immune Cell Function and Interaction (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Herpesvirus Infections and Treatments (3 papers). Suzu Igarashi is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Herpesvirus Infections and Treatments (3 papers). Suzu Igarashi collaborates with scholars based in United States. Suzu Igarashi's co-authors include Li‐Wen Lai, John Sidney, Michael Houghton, Alessandro Sette, Ann L. Erickson, Austin L. Hughes, Denise M. McKinney, Christopher M. Walker, Yoichi Kimura and Felicia Goodrum and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Suzu Igarashi

16 papers receiving 836 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes

2001 321 citations Ann L. Erickson, Yoichi Kimura et al. Immunity profile →

Peers

Countries citing papers authored by Suzu Igarashi

Since Specialization

Citations

This map shows the geographic impact of Suzu Igarashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzu Igarashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzu Igarashi more than expected).

Fields of papers citing papers by Suzu Igarashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzu Igarashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzu Igarashi. The network helps show where Suzu Igarashi may publish in the future.

Co-authorship network of co-authors of Suzu Igarashi

This figure shows the co-authorship network connecting the top 25 collaborators of Suzu Igarashi. A scholar is included among the top collaborators of Suzu Igarashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzu Igarashi. Suzu Igarashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells 2021 ·Science Immunology ·Tae Jin Yun, Suzu Igarashi, Haoquan Zhao, Oriana A. Perez, Marcus R. Pereira, Emmanuel Zorn, Yufeng Shen, Felicia Goodrum, Adeeb Rahman, Peter A. Sims, Donna L. Färber, Boris Reizis	40
2	FOXO transcription factors activate alternative major immediate early promoters to induce human cytomegalovirus reactivation 2020 ·Proceedings of the National Academy of Sciences ·Andrew Hale, Donna Collins-McMillen, Erik M. Lenarcic, Suzu Igarashi, Jeremy P. Kamil, Felicia Goodrum, Nathaniel J. Moorman	28
3	Host signaling and EGR1 transcriptional control of human cytomegalovirus replication and latency 2019 ·PLoS Pathogens ·Jason Buehler, (unknown), (unknown), Suzu Igarashi, Michael Rak, Iliyana Mikell, Jay A. Nelson, Felicia Goodrum	45
4	Virus Control of Trafficking from Sorting Endosomes 2018 ·mBio ·(unknown), (unknown), Suzu Igarashi, Jean M. Wilson, Julie G. Donaldson, Felicia Goodrum	23
5	Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection 2017 ·The Journal of Experimental Medicine ·Claire L. Gordon, Michelle Miron, Joseph J.C. Thome, N. Matsuoka, Joshua Weiner, Michael Rak, Suzu Igarashi, Tomer Granot, Harvey Lerner, Felicia Goodrum, Donna L. Färber	101
6	The Novel Small Molecule Inhibitor, OSU-T315, Suppresses Vestibular Schwannoma and Meningioma Growth by Inhibiting PDK2 Function in the AKT Pathway Activation. 2016 ·PubMed ·Melania E. Mercado-Pimentel, Suzu Igarashi, (unknown), (unknown), Craig Miller, (unknown), Abraham Jacob	9
7	Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe 2016 ·Otology & Neurotology ·Melania E. Mercado-Pimentel, Craig Miller, (unknown), (unknown), (unknown), (unknown), Suzu Igarashi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Abraham Jacob	7
8	Zebrafish swimming behavior as a biomarker for ototoxicity-induced hair cell damage: a high-throughput drug development platform targeting hearing loss 2015 ·Translational research ·(unknown), (unknown), Suzu Igarashi, (unknown), (unknown), (unknown), Hung C. Tran, (unknown), Marvin J. Slepian, Abraham Jacob	30
9	The Solid Component of Radiographically Non-Growing, Post-Radiated Vestibular Schwannoma Retains Proliferative Capacity 2015 ·Annals of Otology Rhinology & Laryngology ·Abraham Jacob, Suzu Igarashi, (unknown), Rihan Khan, Richa Jain	5
10	A Novel High‐Throughput Ototoxicity Assay in Zebrafish: Platform for Drug Development Targeting Hearing Loss 2014 ·Otolaryngology ·(unknown), (unknown), Suzu Igarashi, Edward A. Meister, (unknown), Abraham Jacob	1
11	Molecular Pathogenesis of Vestibular Schwannomas: Insights for the Development of Novel Medical Therapies 2012 ·Otolaryngologia Polska ·Craig Miller, Suzu Igarashi, Abraham Jacob	4
12	Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene 2008 ·Gastroenterology ·Tao Li, Liqun Bai, Jing Li, Suzu Igarashi, Fayez K. Ghishan	17
13	A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury 2007 ·Kidney International ·Li‐Wen Lai, (unknown), Suzu Igarashi, (unknown)	63
14	S1P1-selective agonist, SEW2871, ameliorates ischemic acute renal failure 2006 ·Kidney International ·Yeong‐Hau H. Lien, (unknown), (unknown), Suzu Igarashi, Li‐Wen Lai	115
15	The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes breakdown → 2001 ·Immunity ·Ann L. Erickson, Yoichi Kimura, Suzu Igarashi, (unknown), Michael Houghton, John Sidney, Denise M. McKinney, Alessandro Sette, Austin L. Hughes, Christopher M. Walker	321
16	p70 lupus autoantigen binds the enhancer of the T-cell receptor beta-chain gene. 1993 ·Proceedings of the National Academy of Sciences ·Helen Messier, Thomas Fuller, (unknown), Howard Brickner, Suzu Igarashi, (unknown), Rati Fotedar, (unknown)	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact